BioAge Labs Inc. (BIOA) vs Nautilus Biotechnolgy, Inc. (NAUT)
A side-by-side comparison of BioAge Labs Inc. and Nautilus Biotechnolgy, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BIOA
BioAge Labs Inc.
$6.15HealthcareDelayed quote: Oct 6, 2026, 3:40 PM EDT
NAUT
Nautilus Biotechnolgy, Inc.
$1.79HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Total return — BIOA vs NAUT
growth of $100 · dividends reinvested · last 2yBIOA -65.3% (-41.1%/yr)NAUT -34.4% (-19.0%/yr)NAUT compounded faster over this window
BIOA NAUT
BIOA vs NAUT: by the numbers
- •BIOA is the larger company ($231M vs $228M market cap).
- •Both run net losses; BIOA's is the smaller (-912.25% vs -29747.89% net margin).
Metrics side by side
Valuation
| Metric | BIOA | NAUT |
|---|---|---|
| P/S ratio | 22.35 | 1198.88 |
| P/B ratio | 0.62 | 1.74 |
Profitability
| Metric | BIOA | NAUT |
|---|---|---|
| Gross margin | 99.39% | 0.00% |
| Operating margin | -1026.28% | 0.00% |
| Net margin | -912.25% | -29747.89% |
| ROE | -25.20% | -43.11% |
| ROIC | -28.14% | -40.52% |
Growth (annualized)
| Metric | BIOA | NAUT |
|---|---|---|
| Total return CAGR (5Y) | N/A | -20.56% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.